Invesaro

Stocks SIMO Financial statements

Financial statements

Silicon Motion Technology CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Silicon Motion Technology CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue556523530457540922946639804886
Cost of revenue282272270235279461480369435458
Gross profit275251261222260461466270369428
Research and development92.4102102110122164189174218263
Selling and marketing25.825.929.325.124.828.831.526.927.534.4
General and administrative17.116.917.617.915.621.831.427.931.437.4
Operating expenses137156156170180215252231278334
Operating income13795.310552.180.524621439.990.993
Interest expense0.130.420.3800.0100.0700
Interest income2.164.276.36.754.641.282.7112.214.59.66
Other non-operating income1.373.655.0319.95.081.4-1.3521.216.547.1
Pre-tax income1399911072.185.624721361107140
Income tax27.72411.87.685.8147.340.18.1818.217.5
Net income1117598.164.479.720017352.989.2123
EBITDA14710611764.69426323361.7116123
EPS, basic0.790.530.680.460.571.431.300.400.660.91
EPS, diluted0.780.520.680.460.571.431.290.400.660.91
Shares, basic (weighted)141143144141139139133133135134
Shares, diluted (weighted)142144145141140140134134135135
Dividend per share0.200.300.300.350.350.500.500.500.50

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents274359285323343360232314276202
Short-term investments3.36.943.612.01
Receivables73.679.191.8109116209206195234212
Inventory24.841.426.126.31139.998.361.351.171.8
Other current assets5.879.576.888.3613.937.812.217.631.236.9
Total current assets477569498565618818788793795943
Property, plant and equipment47.951.410198.5105124139167188219
Lease right-of-use assets8.66.75.628.1514.114.713.2
Goodwill68.75958.317.50
Intangible assets5.237.431.02
Long-term investments0.124.24358.549.2717.117.329.7
Total assets6066946736987429719611,0081,0311,223
Accounts payable31.756.427.730.744.580.83655.617.834.7
Deferred revenue2.46.913.665.0382.1
Short-term debt0.240.570.320
Total current liabilities146177114131159282184213200340
Long-term debt0.370.11
Lease liabilities5.623.882.994.9112.712.411.5
Other non-current liabilities16.922.326.729.525.632.244.860.559.552.5
Total liabilities163200140161184314229273259392
Total debt0.610.670.32
Paid-in capital227242263265275295304321338360
Retained earnings216247302271282412425411433468
Treasury stock-34.8-50
Other comprehensive income-1.032.640.5-0.79-0.35-0.542.61.150.341.34
Shareholders' equity443494532537558658733735772831
Total equity443494532537558658733735772831
Total liabilities and equity6066946736987429719611,0081,0311,223
Shares outstanding141143145139138140132134135134

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income1117598.164.479.720017352.989.2123
Depreciation and amortization9.4810.611.812.413.617.218.921.825.330.2
Stock-based compensation17.415.520.814.614.619.526.717.51726.3
Deferred income tax-3.370.58-1.661.12-0.67-1.74-2.530.43-0.42-0.17
Change in inventory-24.8-22.312.7-10.2-21.7-78.1-10372.14.87-215
Change in payables12.20.46-4.6810.67.3326.40.68-1.6312.8108
Cash from operations12610410877.711717583.914977.161.4
Capital expenditures-12.2-11.7-74.9-11-19.5-24.7-32.9-50.3-44.4-55.1
Acquisitions-2.87
Cash from investing-8.22-14.5-79.634.7-21.5-28.2-32.9-49.1-44.1-27.4
Stock issued0.090.3800
Share buybacks-33.5-26.2-25-45.7-13300-24.3
Dividends paid-22.9-32.1-43.3-44-48.9-54-49.9-16.7-67.3-67.2
Cash from financing2.19-31.7-102-70.3-73.9-99.7-183-16.7-67.3-91.5
Exchange rate effect-0.522.75-1.25-0.98-0.81-0.493.68-1.37-0.410.3
Net change in cash12057.6-73.142.121.846.8-13283.3-34.2-57.6
Free cash flow11392.233.466.797.71505198.832.76.3
Interest paid0.110.370.380.0100.0700
Income taxes paid24.330.913.85.618.523.523436.310.116.7

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $276.23 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin48.3%Gross profit / revenue.
Operating margin10.5%Operating income / revenue.
EBITDA margin13.9%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin15.8%Pre-tax income / revenue.
Net margin13.8%Net income / revenue.
FCF margin0.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin6.9%Cash from operations / revenue.
Effective tax rate12.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)15.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)10.9%Net income / average total assets.
Return on invested capital (ROIC)14.5%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue29.7%Research and development expense / revenue.
Stock-based pay / revenue3.0%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue6.2%Capital expenditures / revenue.
D&A / revenue3.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y10.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-2.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y10.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y15.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-2.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y10.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y2.4%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-24.2%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y2.9%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y6.0%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-19.1%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y5.6%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y37.4%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-10.8%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y9.0%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y37.9%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-11.0%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y9.8%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-20.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-9.9%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-12.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-80.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-50.2%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-42.2%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 5y7.4%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y7.6%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y4.3%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y8.3%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y18.6%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y8.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y10.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.78xCurrent assets / current liabilities.
Quick ratio1.22x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.59x(Cash + short-term investments) / current liabilities.
Liabilities / assets32.1%Total liabilities / total assets.
Working capital$603.8MCurrent assets - current liabilities.
Tangible book value$830.7MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.79xRevenue / average total assets.
Fixed asset turnover4.35xRevenue / average property, plant and equipment.
Inventory turnover7.45xCost of revenue / average inventory.
Days inventory49 days365 x average inventory / cost of revenue.
Receivables turnover3.98xRevenue / average receivables.
Days sales outstanding92 days365 x average receivables / revenue.
Days payables21 days365 x average accounts payable / cost of revenue.
Cash conversion cycle120 daysDays inventory + days sales outstanding - days payables.
FCF conversion5.1%Free cash flow / net income, when net income is positive.
Capex / operating cash flow89.7%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.91Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$0.91Net income per basic share, as reported (split-adjusted).
Revenue per share$6.57Revenue / diluted weighted shares.
FCF per share$0.05Free cash flow / diluted weighted shares.
Operating cash flow per share$0.46Cash from operations / diluted weighted shares.
Book value per share$6.19Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$6.19Tangible book value / shares outstanding.
Cash per share$1.50(Cash + short-term investments) / shares outstanding.
Dividend per share$0.50Dividend declared per common share (paid, when declared is not tagged).
Payout ratio54.8%Dividends paid / net income, when net income is positive.
Dividends / FCF1,068.0%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF386.2%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$9.37BShare price x shares outstanding.
Enterprise value$9.16BMarket cap + total debt - cash - short-term investments.
P/E76.4xMarket cap / net income. Only when net income is positive.
P/S10.6xMarket cap / revenue.
P/B11.3xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book11.3xMarket cap / tangible book value, when positive.
P/FCF1,488xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF153xMarket cap / cash from operations, when positive.
EV/Sales10.3xEnterprise value / revenue.
EV/EBIT98.5xEnterprise value / operating income, when both are positive.
EV/EBITDA74.4xEnterprise value / EBITDA, when both are positive.
EV/FCF1,456xEnterprise value / free cash flow, when both are positive.
FCF yield0.1%Free cash flow / market cap.
Earnings yield1.3%Net income / market cap (the inverse of P/E).
Dividend yield0.7%Dividends paid over the period / market cap.
Shareholder yield1.0%(Dividends paid + share buybacks) / market cap.
What was Silicon Motion Technology CORP's revenue in fiscal 2025?

Silicon Motion Technology CORP reported revenue of $885.6M for fiscal 2025, 10.2% higher than the year before.

Was Silicon Motion Technology CORP profitable in fiscal 2025?

Yes. Net income was $122.6M, a net margin of 13.8%.

How much free cash flow did Silicon Motion Technology CORP generate in fiscal 2025?

Cash from operations of $61.4M minus capital expenditures of $55.1M left free cash flow of $6.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Silicon Motion Technology CORP